Large-scale merger and acquisition eyed among small- and medium-sized wholesalers

Published: 2002-11-19 06:57:00

Updated: 2002-11-19 06:57:00

Stimulated by the prevailing business recession, movement of pharmaceutical firms towards wholesaler's margin reduction, fierce competition and more strict administrative regulations on drug prices, small- and medium-sized are struggling with their survival via large-scale merger and acquisition....

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK